Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis.

MLA

Wang, Bingchen, et al. “Comprehensive Evaluation of Clinical Outcomes in Hepatic Epithelioid Hemangioendothelioma Subsets: Insights from SEER Database and Departmental Cohort Analysis.” Frontiers in Immunology, vol. 15, Oct. 2024, p. 1491922. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1491922.

APA

Wang, B., Chen, X., Li, R., Ai, B., Ye, F., Zhao, J., Zhang, Y., Huang, Z., Li, Z., Bi, X., Zhao, H., Cao, D., Cai, J., Zhou, J., & Yan, T. (2024). Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis. Frontiers in Immunology, 15, 1491922. https://doi.org/10.3389/fimmu.2024.1491922

Chicago

Wang, Bingchen, Xiao Chen, Rongxuan Li, Bolun Ai, Feng Ye, Jianjun Zhao, Yefan Zhang, et al. 2024. “Comprehensive Evaluation of Clinical Outcomes in Hepatic Epithelioid Hemangioendothelioma Subsets: Insights from SEER Database and Departmental Cohort Analysis.” Frontiers in Immunology 15 (October): 1491922. doi:10.3389/fimmu.2024.1491922.